Cite
HARVARD Citation
Sy, A. et al. (2019). Heterozygosity for CMT Type 4 Predicts a Severe Vincristine-induced Polyneuropathy Phenotype. Journal of pediatric hematology/oncology. 41 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sy, A. et al. (2019). Heterozygosity for CMT Type 4 Predicts a Severe Vincristine-induced Polyneuropathy Phenotype. Journal of pediatric hematology/oncology. 41 (1), p. . [Online].